How is the Bioline Rx Ltd - ADR today?

The Bioline Rx Ltd - ADR today is trading in the green, up by 10.43% at 4.66.

What is Bioline Rx Ltd - ADR Annual Revenue?

Bioline Rx Ltd - ADR Annual Revenue rose 502.92%, in the last year to $28.94 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Bioline Rx Ltd - ADR Annual Net Profit?

Bioline Rx Ltd - ADR Annual Net Profit rose 84.79% in the last year to $9.22 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Bioline Rx Ltd - ADR Price to Earning Ratio?

Bioline Rx Ltd - ADR Price to Earning Ratio is -5.1, which is negative.

What is Bioline Rx Ltd - ADR Stock Price?

Bioline Rx Ltd - ADR Stock Price fell 83.33% and underperformed its sector by 111.77% in the past year.

What is Bioline Rx Ltd - ADR Quarterly Revenue?

Bioline Rx Ltd - ADR Quarterly Revenue fell 96.28% YoY to $0.26 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Bioline Rx Ltd - ADR Quarterly Net profit?

Bioline Rx Ltd - ADR Quarterly Net profit rose 836.64% YoY to $5.13 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Bioline Rx Ltd - ADR Debt to Equity Ratio?

Bioline Rx Ltd - ADR Debt to Equity Ratio of 1.12 is higher than 1. This implies that company assets are financed through debt.

What is Bioline Rx Ltd - ADR Return on Equity(ROE)?

Bioline Rx Ltd - ADR Return on Equity(ROE) for the last financial year was -69.11%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Bioline Rx Ltd - ADR Mutual Fund Holding?

Bioline Rx Ltd - ADR Mutual Fund Holding increased by 0.01% in the last quarter to 0.14.

What is Bioline Rx Ltd - ADR Interest Coverage Ratio?

Bioline Rx Ltd - ADR Interest Coverage Ratio is -0.02, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Bioline Rx Ltd - ADR Institutional Holding?

Bioline Rx Ltd - ADR Institutional Holding decreased by 0.15% in the last quarter to 1.15.

Bioline Rx Ltd - ADR XNAS: BLRX

Bioline Rx Ltd - ADR Live Share Price Today, Share Analysis and Chart

Name: Bioline Rx Ltd - ADR: Is Infosys Ltd. worth buying?
Item: Bioline Rx Ltd - ADR
Rating: 1.65800
Author: Trendlyne DVM scores

about

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for th...

4.66 0.44 (10.43%)

86.91% Fall from 52W High

266.3K XNAS Volume

High vol.+gain this week

XNAS 04 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

27.0 / 100

Technically Neutral

39.3 / 100

26

1Yr Price target upside is 458%

3 analysts

Bioline Rx Ltd - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bioline Rx Ltd - ADR FAQ

How is Bioline Rx Ltd - ADR today?

Bioline Rx Ltd - ADR today is trading in the green, and is up by 10.43% at 4.66.

How has Bioline Rx Ltd - ADR performed historically?

Bioline Rx Ltd - ADR is currently trading up 10.43% on an intraday basis. In the past week the stock rose 22.96%. stock has been up 51.79% in the past quarter and fell -83.33% in the past year. You can view this in the overview section.